Management of Portal Hypertension

Area of Science:

• Hepatology
• Gastroenterology
• Medical Imaging

Background:

• Cirrhosis leads to portal hypertension, causing severe clinical issues like ascites, variceal bleeding, and hepatic encephalopathy.
• Hepatic venous pressure gradient (HVPG) measurement is the gold standard for diagnosing cirrhosis-related portal hypertension.
• Clinically significant portal hypertension (CSPH) is defined as HVPG > 10 mmHg, indicating elevated complication risk.

Purpose of the Study:

• To provide a comprehensive review of the diagnosis and management of cirrhosis-related portal hypertension.
• To discuss traditional and emerging diagnostic methods for CSPH.
• To highlight historical context and future research directions in portal hypertension.

Main Methods:

• Review of existing literature on portal hypertension diagnosis and management.
• Discussion of hepatic venous pressure gradient measurement as the gold standard.
• Exploration of non-invasive clinical, laboratory, and imaging techniques for CSPH diagnosis.
• Evaluation of recent advancements in deep learning for CSPH detection.

Main Results:

• Portal hypertension is a critical determinant of cirrhosis complications.
• HVPG > 10 mmHg signifies CSPH, necessitating clinical attention.
• Deep learning models demonstrate high efficacy in diagnosing CSPH.
• Non-invasive methods offer valuable adjuncts to HVPG measurement.

Conclusions:

• Accurate diagnosis of portal hypertension and CSPH is crucial for managing cirrhosis complications.
• Deep learning presents a promising, effective tool for CSPH diagnosis.
• Individualized management strategies are essential for patients with portal hypertension.